Venous thromboembolism in cancer patients undergoing major surgery

Annals of Surgical Oncology

Volumn 15, Issue 12, 2008, Pages 3567-3578

  Osborne, Nicolas H ^a   Wakefield, Thomas W ^a   Henke, Peter K ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; DALTEPARIN; DOXORUBICIN; ENOXAPARIN; FLUOROURACIL; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; OXALIPLATIN; PLACEBO; WARFARIN;

ABDOMINAL CANCER; ABDOMINAL SURGERY; ANGIOGENESIS; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CATHETER; CELL INTERACTION; CLINICAL TRIAL; COLORECTAL CANCER; DOSAGE SCHEDULE COMPARISON; DRUG COST; DRUG DOSE COMPARISON; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; INCIDENCE; INDWELLING CATHETER; INFORMATION RETRIEVAL; MEDLINE; PATHOPHYSIOLOGY; PELVIS SURGERY; PRACTICE GUIDELINE; RISK FACTOR; SOLID TUMOR; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; META-ANALYSIS AS TOPIC; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VENOUS THROMBOEMBOLISM;

EID: 58149288404     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-0151-4     Document Type: Article

References (63)

1. Trousseau A. Phlegmasia alba dolens. In: Clinique Medicale de L'Hotel-Dieu Paris. London: New Sydenham Society, 1865:94-96
2. MD Silverstein JA Heit DN Mohr 1998 Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study Arch Intern Med 158 585 93
3. JA Heit MD Silverstein DN Mohr 2000 Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study Arch Intern Med 160 809 15
4. PD Stein A Beemath FA Meyers 2006 Incidence of venous thromboembolism in patients hospitalized with cancer Am J Med 119 60 8
5. JW Blom CJ Doggen S Osanto 2005 Malignancies, prothrombotic mutations, and the risk of venous thrombosis JAMA 293 715 22
6. JW Blom JP Vanderschoot MJ Oostindiër 2006 Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study J Thromb Haemost 4 529 35
7. RH White HK Chew H Zhou 2005 Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults Arch Intern Med 165 1782 7
8. GH Sack Jr J Levin WR Bell 1977 Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features Medicine (Baltimore) 56 1 37
9. MR Nijziel R van Oerle HF Hillen 2006 From Trousseau to angiogenesis: the link between the haemostatic system and cancer Neth J Med 64 403 10
10. GJ Caine PS Stonelake GY Lip 2002 The hypercoagulable state of malignancy: pathogenesis and current debate Neoplasia 4 465 73
11. A Falanga 1998 Mechanisms of hypercoagulation in malignancy and during chemotherapy Haemostasis 28 Suppl 3 50 60
12. FR Rickles A Falanga 2001 Molecular basis for the relationship between thrombosis and cancer Thromb Res 102 V215 24
13. CM Floyd K Irani PD Kind 1992 von Willebrand factor interacts with malignant hematopoietic cell lines: evidence for the presence of specific binding sites and modification of von Willebrand factor structure and function J Lab Clin Med 119 467 76
14. SG Gordon BA Cross 1990 An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker Cancer Res 50 6229 34
15. M Schmitt N Harbeck C Thomssen 1997 Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy Thromb Haemost 78 285 96
16. J Folkman 1971 Tumor angiogenesis: therapeutic implications N Engl J Med 285 1182 6
17. GA Paspatis A Sfyridaki N Papanikolaou 2002 Resistance to activated protein C, factor V leiden and the prothrombin G20210A variant in patients with colorectal cancer Pathophysiol Haemost Thromb 32 2 7
18. T Barbui G Finazzi A Falanga 1998 The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia Blood 91 3093 102
19. FR Rickles MN Levine 1998 Venous thromboembolism in malignancy and malignancy in venous thromboembolism Haemostasis 28 Suppl 3 43 9
20. N Levitan A Dowlati SC Remick 1999 Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data Medicine (Baltimore) 78 285 91
21. A Seddighzadeh R Shetty SZ Goldhaber 2007 Venous thromboembolism in patients with active cancer Thromb Haemost 98 3 656 61
22. WH Geerts GF Pineo JA Heit 2004 Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3 Suppl 338S 400S
23. G Agnelli G Bolis L Capussotti 2006 A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS Project Ann Surg 243 89 95
24. RM Scarpa G Carrieri G Gussoni 2007 Clinically overt venous thromboembolism after urologic cancer surgery: results from the @RISTOS Study Eur Urol 51 130 5
25. RH Andtbacka G Babiera SE Singletary 2006 Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways Ann Surg 243 96 101
26. A Alcalay T Wun V Khatri 2006 Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival J Clin Oncol 24 1112 8
27. MT Stender TS Nielsen JB Frøkjaer 2007 High preoperative prevalence of deep venous thrombosis in patients with colorectal cancer Br J Surg 94 1100 3
28. HK Chew T Wun D Harvey 2006 Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 458 64
29. TC Haddad EW Greeno 2006 Chemotherapy-induced thrombosis Thromb Res 118 555 68
30. MN Levine M Gent J Hirsh 1988 The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer N Engl J Med 318 404 7
31. PC Clahsen CJ van de Velde JP Julien 1994 Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study J Clin Oncol 12 1266 71
32. KI Pritchard AH Paterson NA Paul 1996 Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group J Clin Oncol 14 2731 7
33. MN Levine 1997 Prevention of thrombotic disorders in cancer patients undergoing chemotherapy Thromb Haemost 78 133 6
34. LT Goodnough H Saito A Manni 1984 Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients Cancer 54 1264 8
35. HM Otten J Mathijssen H ten Cate 2004 Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon Arch Intern Med 164 190 4
36. M Levine J Hirsh M Gent 1994 Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer Lancet 343 886 9
37. AA Khorana CW Francis E Culakova 2005 Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study Cancer 104 2822 9
38. J Lin TW Wakefield PK Henke 2006 Risk factors associated with venous thromboembolic events in patients with malignancy Blood Coagul Fibrinolysis 17 265 70
39. AK Kakkar RC Williamson 1999 Prevention of venous thromboembolism in cancer patients Semin Thromb Hemost 25 239 43
40. C Riber N Alstrup T Nymann 1996 Postoperative thromboembolism after day-case herniorrhaphy Br J Surg 83 420 1
41. S Törngren G Hägglund K Molin 1980 Postoperative deep venous thrombosis and infectious complications. A clinical study of patients undergoing colo-rectal surgery Scand J Infect Dis 12 123 7
42. S Törngren A Rieger 1982 Prophylaxis of deep venous thrombosis in colorectal surgery Dis Colon Rectum 25 563 6
43. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. Venous thromboembolic disease, v1.2007. Available at: http://www.nccn.org/professionals/physician-gls/PDF/vte.pdf. Accessed 23 November 2007
44. GA Colditz RL Tuden G Oster 1986 Rates of venous thrombosis after general surgery: combined results of randomised clinical trials Lancet 2 143 6
45. P Wille-Jørgensen MS Rasmussen BR Andersen 2003 Heparins and mechanical methods for thromboprophylaxis in colorectal surgery Cochrane Database Syst Rev 4 CD001217
46. P Wille-Jørgensen J Kjaergaard 1985 Prophylaxis of postoperative deep venous thrombosis JAMA 253 1120
47. P Mismetti S Laporte JY Darmon 2001 Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery Br J Surg 88 913 30
48. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. ENOXACAN Study Group. Br J Surg 1997; 84:1099-103
49. RS McLeod WH Geerts KW Sniderman 2001 Subcutaneous heparin versus low-molecular-weight heparin as thromboprophylaxis in patients undergoing colorectal surgery: results of the Canadian colorectal DVT prophylaxis trial: a randomized, double-blind trial Ann Surg 233 438 44
50. D Bergqvist US Burmark PA Flordal 1995 Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients Br J Surg 82 496 501
51. E Etchells RS McLeod W Geerts 1999 Economic analysis of low-dose heparin vs the low-molecular-weight heparin enoxaparin for prevention of venous thromboembolism after colorectal surgery Arch Intern Med 159 1221 8
52. G Agnelli D Bergqvist AT Cohen 2005 PEGASUS Investigators. Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery Br J Surg 92 1212 20
53. AG Turpie KA Bauer JA Caprini 2007 Apollo Investigators. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison J Thromb Haemost 5 1854 61
54. JH Scurr PD Coleridge-Smith JH Hasty 1988 Deep venous thrombosis: a continuing problem BMJ 297 28
55. D Bergqvist G Agnelli AT Cohen 2002 Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer N Engl J Med 346 975 80
56. MS Rasmussen 2002 Preventing thromboembolic complications in cancer patients after surgery: a role for prolonged thromboprophylaxis Cancer Treat Rev 28 141 4
57. AK Kakkar MN Levine Z Kadziola 2004 Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the Fragmin Advanced Malignancy Outcome Study (FAMOUS) J Clin Oncol 22 1944 8
58. CP Klerk SM Smorenburg HM Otten 2005 The effect of low molecular weight heparin on survival in patients with advanced malignancy J Clin Oncol 23 2130 5
59. AY Lee FR Rickles JA Julian 2005 Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism J Clin Oncol 23 2123 9
60. DM Arnold SR Kahn I Shrier 2001 Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines Chest 120 1964 71
61. JA Caprini JI Arcelus JJ Reyna 2001 Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease Semin Hematol 38 2 Suppl 5 12 9
62. D Bergqvist JA Caprini O Dotsenko 2007 Venous thromboembolism and cancer Curr Probl Surg 44 157 216
63. N Kucher S Koo R Quiroz 2005 Electronic alerts to prevent venous thromboembolism among hospitalized patients N Engl J Med 352 969 77